Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NCAM1 antisense RNA 2 (NCAM1-AS2) is a long non-coding natural antisense RNA transcribed from the opposite strand of the NCAM1 gene locus[1]. It does not encode a protein but is thought to regulate the expression of the NCAM1 gene by mechanisms such as transcriptional interference, chromatin modification, or RNA duplex formation[3]. In mouse developmental studies, Ncam1 antisense ncRNAs are expressed in the brain, heart, liver, lung, kidney, and other tissues, with developmental and cell-specific patterns; they may co-localize with Ncam1 mRNA, suggesting a regulatory function[1]. The detailed cellular and disease roles of NCAM1-AS2 in humans are not yet fully characterized, but it is part of the rapidly growing field of antisense lncRNAs, which can play roles in development, differentiation, and potentially pathology including cancer[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NCAM1 antisense RNA 2 (NCAM1-AS2).